Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from PhRMA

WATCH: Axios' Future of Health Summit 2026

Tune in to Axios Live's second annual Future of Health Summit.

Axios

Pharma's Direct-To-Patient Wave Hits Novartis Next

The Pharmaceutical Research and Manufacturers of America (PhRMA) outlined initiatives to bolster U.S. manufacturing, ease patient costs, and improve access to medicine.

Benzinga

Trump threatens 100% tariffs on drugmakers who aren't building U.S. plants

The move raises the stakes for drug manufacturers already under pressure from the administration to lower U.S. prices.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Australian exporters brace for immediate US tariffs on Trump’s ‘liberation day’

Government ministers still in the dark on tariffs as White House dangles hope of ‘good negotiation’ with president

The Guardian - AU

Big pharma is taking aim at Australia’s PBS. Could Trump force us to pay more for medicines?

Big pharma US wants to sell more drugs in Australia for more and its demands are now entangled with the ongoing trade tariff war

The Guardian - AU

US Pharma Lobby Targets Australia's AU$18B PBS, Urges Trump To Impose Punitive Tariffs

On March 11, a formal complaint was submitted to US Trade Representative Jamieson Greer, urging the Trump administration to take strong action against Australia's "damaging pricing policies."

International Business Times

President-Elect Trump Hosts Pharmaceutical Ceos For Dinner At Mar-A-Lago

President-elect Trump's dinner with pharmaceutical executives and healthcare appointees highlights industry collaboration and healthcare challenges.

Top News

Read news from The Economist, FT, and more,
with one subscription

Biggest lobbying interests buck trend with higher 2024 spending - Roll Call

Trade groups and companies responsible for this year's largest lobbying expenditures so far upped the ante in the first half of 2024.

Roll Call

US pharma group opposing abortion pill restrictions also backs Republicans attacking drug

Group advocating to preserve FDA judgment in supreme court case also gave $125,000 to Republicans opposing mifepristone

The Guardian - US

Senators ask CEOs why their drugs cost so much more in the U.S.

The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.

WEKU

FDA approves Florida's plan to import cheaper drugs from Canada

The Food and Drug Administration's authorization of Florida's plan to import prescription medicines from Canada is a first. But the state still has hurdles to clear before imports could begin.

WEKU

FDA greenlights Florida’s drug importation plan - Roll Call

The approval makes Florida the first state to receive approval to import drugs and comes comes after three years of delay and two lawsuits.

Roll Call

The inescapable ad campaign for a wonky drug policy debate - Roll Call

A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a familiar face.

Roll Call

Here are the drugs Biden is targeting first for Medicare price-lowering talks

A pharmaceuticals lobbying group is criticizing the list of drugs President Joe Biden says he’s targeting for price negotiations to cut Medicare costs

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

See which drugs Biden is targeting first for Medicare price-lowering talks

A pharmaceuticals lobbying group is criticizing the list of drugs President Joe Biden says he’s targeting for price negotiations to cut Medicare costs

Fortune

Biden targets diabetes drug Jardiance, blood thinner Eliquis, and 8 others for controversial Medicare price talks. But any relief is still years away

The move is expected to cut costs in a few years for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers.

Roll Call

HHS lists first 10 drugs subject to Medicare price negotiation - Roll Call

The program is a major priority for Joe Biden, who ran for president in part on the promise to allow Medicare to negotiate drug prices.

WEKU

What's a fair price for a prescription drug? Medicare's about to weigh in

Medicare soon will start something it hasn't done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Drugmaker lobbying group sues over plan to negotiate Medicare drug prices

A key drugmaker lobbying group has joined the legal fight against the federal government’s plan to negotiate Medicare drug prices

WEKU

The pharmaceutical industry urges courts to preserve access to abortion pill

As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.

Los Angeles Times

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

WEKU

Medicare announces plan to recoup billions from drug companies

Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.

The Independent UK

EXPLAINER: Lower prescription prices to take time in new law

After decades of failed attempts, Democrats this month passed legislation that aims to reign in the soaring costs of drugs for some in the United States

WEKU

Congress is about to act on drug price reform. Here's what you need to know

A deal on the table in Congress would help deliver on a long-time promise: to make prescription drugs more affordable. It includes a $2,000 cap on out-of-pocket expenses for Medicare patients.

Roll Call

Groups launch last-ditch effort against drug pricing changes - Roll Call

Interest groups are spending millions in hopes of blocking legislation allowing Medicare to demand lower prices for prescription drugs.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations